New Nordic Healthbrands AB (FRA:N9X) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
New Nordic Healthbrands AB EBITDA Margin % Related Terms
New Nordic Healthbrands AB EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:N9X vs KHC, GIS, JBS: EBITDA Margin % Comparison
For the Packaged Foods subindustry, New Nordic Healthbrands AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Nordic Healthbrands AB EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where New Nordic Healthbrands AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Nordic Healthbrands AB (FRA:N9X) has a EBITDA Margin % of -0.65% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on New Nordic Healthbrands AB and its competitors. According to the industry distribution chart, New Nordic Healthbrands AB ranks #1532 out of 1952 companies in the Consumer Packaged Goods industry, placing it in the top 78.5%.
Is New Nordic Healthbrands AB's EBITDA Margin % too high?
New Nordic Healthbrands AB's current EBITDA Margin % is -0.65%. Based on the distribution chart, New Nordic Healthbrands AB ranks #1532 out of 1952 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, New Nordic Healthbrands AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, New Nordic Healthbrands AB ranks #1532 out of 1952 companies for EBITDA Margin %. This places New Nordic Healthbrands AB in the lower half of its industry. The industry median EBITDA Margin % is 8.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.98, based on 1,952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on New Nordic Healthbrands AB and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current EBITDA Margin % is -0.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current EBITDA Margin % of -0.65%. The stock's GF Value™ is €1.72, compared to a current price of €1.04 — trading 39.8% below its estimated fair value. The current EBITDA Margin % is -0.65%. New Nordic Healthbrands AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current EBITDA Margin % is -0.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?
Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued.
The current stock price of €1.04 is trading 39.8% below its estimated GF Value™ of €1.72.
Key valuation signals for FRA:N9X:
EBITDA Margin %: -0.65%
GF Value™: €1.72 vs. price of €1.04 (39.8% below fair value)
No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
63GF Score
Get the complete analysis for FRA:N9X
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N9X has been successfully added to your 
